Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

90.63
Delayed Data
As of Sep 23
 -1.49 / -1.62%
Today’s Change
75.90
Today|||52-Week Range
134.71
-27.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash559.4M569.3M633.7M793.7M
 
 
 
 
 
Short Term Investment Cash14.1M79.9M56.0M77.8M
 
 
 
 
 
Cash & Short Term Investments1.4B1.5B1.4B1.1B
 
 
 
 
 
 
ReceivablesReceivables143.3M85.5M90.1M189.3M
 
 
 
 
 
 
InventoriesInventories30.5M14.1M30.8M57.2M
 
 
 
 
 
 
Current AssetsPrepaid Expenses----17.6M22.1M
 
 
 
Other Current Assets24.7M23.8M10.5M12.1M
 
 
 
 
 
Current Assets1.6B1.6B1.5B1.4B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross730.3M1.0B994.2M1.0B
 
 
 
 
 
Depreciation-296.7M-308.3M-278.4M-336.1M
 
 
 
 
 
Intangible Assets694.5M31.0M68.9M334.7M
 
 
 
 
 
Other Assets704.2M33.4M72.4M341.9M
 
 
 
 
 
Total Assets2.8B2.3B2.3B2.5B
 
 
 
 
 
 
LiabilitiesAccounts Payable101.3M49.3M71.2M74.9M
 
 
 
 
 
Short Term Debt13.7M16.9M32.0M87.0M
 
 
 
 
 
Accrued Expenses196.3M89.8M141.6M141.4M
 
 
 
 
 
Other Current Liabilities243.5M244.2M173.9M256.5M
 
 
 
 
 
Other Liabilities432.6M397.8M368.3M506.3M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt683.2M489.7M792.9M739.5M
 
 
 
 
 
Deferred Taxes-280.4M0.00-15.0M-110.4M
 
 
 
 
Other Liabilities32.5M11.6M34.5M31.8M
 
 
 
 
 
Total Liabilities1.5B962.6M1.2B1.4B
 
 
 
 
 
 
EquityMinority Interest-55.9M-242.5M-4.2M-31.8M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity999.2M1.4B1.1B940.0M
 
 
 
 
 
Total Shareholder Equity999.2M1.4B1.1B940.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding217.3M233.8M241.8M246.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.